Pilulka pharmacies ups sales by 4 pct to over Kc2.5bn in 2022

Prague, Jan 5 (CTK) - Czech pharmacy group Pilulka raised sales by 4 percent yr/yr to over Kc2.5bn in 2022, according to preliminary unaudited results, and franchise pharmacy network Pilulka added nearly Kc1bn to total sales of Kc3.5bn, the firm told CTK today.

Pilulka expanded to new markets last year, having entered Austria as Pilulka.at in December and Hungary as Pilulka.hu in October. It is also active in Slovakia and Romania.

"Last year, Pilulka served almost 750,000 unique customers who made over 1.4 million orders," the company said.

Sales grew despite a shortfall in the COVID-19 product range whose sales declined by Kc170m in annual terms.

Pilulka sold seven brick-and-mortar pharmacies.

Piluka operates a network of brick-and-mortar pharmacies and the largest mail-order pharmacy in Czechia and Slovakia with about two million customers.

Active in Czechia and Slovakia since 2013, Pilulka has over 140 brick-and-mortar pharmacies in Czechia, according to its website. Czechia's largest pharmacy network is Dr.Max of Penta group, with about 460 branches.

In 2023, Pilulka group will focus on increasing profitability, limiting loss-making activities, utilising investments and enhancing operational efficiency, the firm said.

This year, sales ought to rise at the level of inflation.

With its shares traded on the Prague Stock Exchange (BCPP), Pilulka is majority owned by Czech natural persons.

hja/er/vr

CZ0009009874